Sandoz obtained a optimistic CHMP opinion for a citrate-free high-concentration formulation of adalimumab biosimilar | Jobi Cool
Sandoz is in search of approval of high-concentration (HCF) adalimumab to be used in all indications of the reference medication As soon as authorised, the HCF formulation will supply sufferers an improved but acquainted expertise by way of elevated consolation and lowered injection quantity The advice additional helps the enlargement of the Sandoz biosimilar immunology … Read more